Retatrutide 20mg

Retatrutide is a next-generation triple agonist peptide that targets GLP-1, GIP, and glucagon receptors simultaneously, a three-pathway mechanism that sets it apart from single-agonist peptides like Semaglutide and dual-agonists like Tirzepatide.

By acting on all three hormonal pathways at once, Retatrutide suppresses appetite, increases energy expenditure, and accelerates fat metabolism. Clinical research has demonstrated unprecedented weight-loss potential, with body mass reductions surpassing earlier-generation peptides.

Beyond fat loss, Retatrutide supports insulin sensitivity, glucose regulation, and overall metabolic efficiency, with significant implications for cardiovascular and metabolic health. Its ability to combine appetite control with increased energy utilization makes it one of the most advanced peptides in modern metabolic research.